MannKind Corporation
High capacity diketopiperazine microparticles and methods

Last updated:

Abstract:

Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.

Status:
Grant
Type:

Utility

Filling date:

10 Jan 2020

Issue date:

6 Sep 2022